skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 61,971  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Female remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Vaccine protection against Zika virus from Brazil
Material Type:
Article
Add to My Research

Vaccine protection against Zika virus from Brazil

Nature (London), 2016-08, Vol.536 (7617), p.474-478 [Peer Reviewed Journal]

COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group Aug 25, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature18952 ;PMID: 27355570 ;CODEN: NATUAS

Full text available

2
Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge
Material Type:
Article
Add to My Research

Inactivated Rabies Virus-Based Ebola Vaccine Preserved by Vaporization Is Heat-Stable and Immunogenic Against Ebola and Protects Against Rabies Challenge

The Journal of infectious diseases, 2019-11, Vol.220 (9), p.1521-1528 [Peer Reviewed Journal]

Published by Oxford University Press for the Infectious Diseases Society of America 2019. ;Published by Oxford University Press for the Infectious Diseases Society of America 2019. 2019 ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiz332 ;PMID: 31374568

Full text available

3
Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study
Material Type:
Article
Add to My Research

Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study

Vaccine, 2018-06, Vol.36 (28), p.4102-4111 [Peer Reviewed Journal]

2018 ;Copyright © 2018. Published by Elsevier Ltd. ;Copyright Elsevier Limited Jun 27, 2018 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2018.05.046 ;PMID: 29784470

Full text available

4
Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial
Material Type:
Article
Add to My Research

Immunogenicity, safety, and tolerability of the measles-vectored chikungunya virus vaccine MV-CHIK: a double-blind, randomised, placebo-controlled and active-controlled phase 2 trial

The Lancet (British edition), 2018-12, Vol.392 (10165), p.2718-2727 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 22, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32488-7 ;PMID: 30409443

Full text available

5
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Material Type:
Article
Add to My Research

BNT162b vaccines protect rhesus macaques from SARS-CoV-2

Nature (London), 2021-04, Vol.592 (7853), p.283-289 [Peer Reviewed Journal]

Copyright Nature Publishing Group Apr 8, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03275-y ;PMID: 33524990

Full text available

6
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
Material Type:
Article
Add to My Research

Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial

Vaccine, 2016-01, Vol.34 (3), p.313-319 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 12, 2016 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.11.056 ;PMID: 26657184

Full text available

7
Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad® ) administered concomitantly with a booster dose of a hexavalent vaccine in 12–23-month-old infants
Material Type:
Article
Add to My Research

Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad® ) administered concomitantly with a booster dose of a hexavalent vaccine in 12–23-month-old infants

Vaccine, 2015-05, Vol.33 (20), p.2379-2386 [Peer Reviewed Journal]

Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 11, 2015 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.02.070 ;PMID: 25765966

Full text available

8
Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine
Material Type:
Article
Add to My Research

Immunogenicity of a combination vaccine containing diphtheria toxoid, tetanus toxoid, three-component acellular pertussis, hepatitis B, inactivated polio virus, and Haemophilus influenzae type b when given concomitantly with 13-valent pneumococcal conjugate vaccine

Vaccine, 2011-08, Vol.29 (35), p.6042-6048 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 11, 2011 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.06.026 ;PMID: 21704105 ;CODEN: VACCDE

Full text available

9
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Material Type:
Article
Add to My Research

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

New England Journal of Medicine, 2020-12, Vol.383 (27), p.2603-2615 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;Copyright © 2020 Massachusetts Medical Society. ;COPYRIGHT 2020 Massachusetts Medical Society ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2020 Massachusetts Medical Society. All rights reserved. 2020 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034577 ;PMID: 33301246

Digital Resources/Online E-Resources

10
Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019
Material Type:
Article
Add to My Research

Relative Effectiveness of Influenza Vaccines Among the United States Elderly, 2018–2019

The Journal of infectious diseases, 2020-06, Vol.222 (2), p.278-287 [Peer Reviewed Journal]

Published by Oxford University Press for the Infectious Diseases Society of America 2020. 2020 ;Published by Oxford University Press for the Infectious Diseases Society of America 2020. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa080 ;PMID: 32100009

Full text available

11
The COVID-19 vaccine development landscape
Material Type:
Article
Add to My Research

The COVID-19 vaccine development landscape

Nature reviews. Drug discovery, 2020-05, Vol.19 (5), p.305-306 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Nature 2020. ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/d41573-020-00073-5 ;PMID: 32273591

Full text available

12
Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients
Material Type:
Article
Add to My Research

Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients

Vaccine, 2015-03, Vol.33 (12), p.1440-1445 [Peer Reviewed Journal]

2015 ;Copyright © 2015. Published by Elsevier Ltd. ;Copyright Elsevier Limited Mar 17, 2015 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.01.075 ;PMID: 25665961

Full text available

13
The Delay in the Licensing of Protozoal Vaccines: A Comparative History
Material Type:
Article
Add to My Research

The Delay in the Licensing of Protozoal Vaccines: A Comparative History

Frontiers in immunology, 2020-03, Vol.11, p.204-204 [Peer Reviewed Journal]

Copyright © 2020 Palatnik-de-Sousa and Nico. ;COPYRIGHT 2020 Frontiers Research Foundation ;Copyright © 2020 Palatnik-de-Sousa and Nico. 2020 Palatnik-de-Sousa and Nico ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2020.00204 ;PMID: 32210953

Full text available

14
Potential for Maternally Administered Vaccine for Infant Group B Streptococcus
Material Type:
Article
Add to My Research

Potential for Maternally Administered Vaccine for Infant Group B Streptococcus

The New England journal of medicine, 2023-07, Vol.389 (3), p.215-227 [Peer Reviewed Journal]

Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2116045 ;PMID: 37467497

Full text available

15
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Material Type:
Article
Add to My Research

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Nature (London), 2021-04, Vol.592 (7855), p.616-622 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Apr 22, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03324-6 ;PMID: 33567448

Full text available

16
Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania
Material Type:
Article
Add to My Research

Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania

Vaccine, 2011-10, Vol.29 (46), p.8417-8428 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Oct 26, 2011 ;ISSN: 0264-410X ;ISSN: 1873-2518 ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2011.08.001 ;PMID: 21864626 ;CODEN: VACCDE

Full text available

17
A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA
Material Type:
Article
Add to My Research

A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA

Vaccine, 2013-10, Vol.31 (42), p.4874-4880 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2013.07.049 ;PMID: 23916987 ;CODEN: VACCDE

Full text available

18
Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine
Material Type:
Article
Add to My Research

Safety and immunogenicity of a Sf9 insect cell-derived respiratory syncytial virus fusion protein nanoparticle vaccine

Vaccine, 2013-01, Vol.31 (3), p.524-532 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 7, 2013 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2012.11.009 ;PMID: 23153449 ;CODEN: VACCDE

Full text available

19
Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis -based vaccine to enter clinical trials
Material Type:
Article
Add to My Research

Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis -based vaccine to enter clinical trials

Vaccine, 2013-10, Vol.31 (42), p.4867-4873 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2013.07.051 ;PMID: 23965219 ;CODEN: VACCDE

Full text available

20
Confronting the barriers to develop novel vaccines against brucellosis
Material Type:
Article
Add to My Research

Confronting the barriers to develop novel vaccines against brucellosis

Expert review of vaccines, 2011-09, Vol.10 (9), p.1291-1305 [Peer Reviewed Journal]

Expert Reviews Ltd 2011 ;COPYRIGHT 2011 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.11.110 ;PMID: 21919619

Full text available

Results 1 - 20 of 61,971  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (58,648)

Refine My Results

Creation Date 

From To
  1. Before 1965  (58)
  2. 1965 To 1979  (1,812)
  3. 1980 To 1994  (4,629)
  4. 1995 To 2010  (20,988)
  5. After 2010  (34,497)
  6. More options open sub menu

Subject 

  1. Science & Technology  (54,250)
  2. Life Sciences & Biomedicine  (49,704)
  3. Humans  (46,747)
  4. Male  (34,816)
  5. Vaccines  (24,532)
  6. Immunology  (23,298)
  7. Animals  (22,571)
  8. Adult  (20,642)
  9. Vaccination  (19,385)
  10. Biological And Medical Sciences  (16,413)
  11. Infectious Diseases  (16,343)
  12. Immunization  (15,506)
  13. Middle Aged  (14,841)
  14. Mice  (14,770)
  15. Adolescent  (14,258)
  16. Microbiology  (13,480)
  17. Child  (11,509)
  18. Medicine, Research & Experimental  (11,109)
  19. Research & Experimental Medicine  (11,096)
  20. More options open sub menu

Language 

  1. English  (60,826)
  2. Japanese  (6,156)
  3. Portuguese  (599)
  4. French  (521)
  5. Spanish  (398)
  6. German  (178)
  7. Norwegian  (77)
  8. Italian  (54)
  9. Russian  (47)
  10. Swedish  (44)
  11. Chinese  (34)
  12. Polish  (23)
  13. Korean  (14)
  14. Turkish  (9)
  15. Serbian  (6)
  16. Icelandic  (6)
  17. Czech  (3)
  18. Croatian  (2)
  19. Afrikaans  (2)
  20. Arabic  (1)
  21. More options open sub menu

Searching Remote Databases, Please Wait